The clinical, radiological, microbiological, and molecular profile of the skin-penetration site of transfemoral amputees treated with bone-anchored prostheses

Maria Lennerås, Georgios Tsikandylakis, Margarita Trobos, Omar Omar, Forugh Vazirisani, Anders Palmquist, Örjan Berlin, Rickard Brånemark, Peter Thomsen, Maria Lennerås, Georgios Tsikandylakis, Margarita Trobos, Omar Omar, Forugh Vazirisani, Anders Palmquist, Örjan Berlin, Rickard Brånemark, Peter Thomsen

Abstract

The breach of the skin barrier is a critical issue associated with the treatment of individuals with transfemoral amputation (TFA) using osseointegrated, percutaneous titanium implants. Thirty TFA patients scheduled for abutment exchange or removal were consecutively enrolled. The aims were to determine the macroscopic skin signs, the presence of bacteria and the gene expression in abutment-adherent cells and to conduct correlative and comparative analyses between the different parameters. Redness and a granulation ring were present in 47% of the patients. Bacteria were detected in 27/30 patients, commonly in the bone canal. Staphylococcus aureus, coagulase-negative staphylococci, streptococci, and Enterococcus faecalis were the most common. A positive correlation was found between TNF-α expression and the detection of S. aureus. Staphylococcus aureus together with other bacterial species revealed a positive relationship with MMP-8 expression. A negative correlation was demonstrated between the length of the residual femur bone and the detection of a granulation ring and E. faecalis. A positive correlation was revealed between fixture loosening and pain and the radiological detection of endosteal bone resorption. Fixture loosening was also correlated with the reduced expression of interleukin-10 and osteocalcin. It is concluded that several relationships exist between clinical, radiological, microbiological, and molecular assessments of the percutaneous area of TFAs. Further long term studies on larger patient cohorts are required to determine the precise cause-effect relationships and unravel the role of host-bacteria interactions in the skin, bone canal and on the abutment for the longevity of percutaneous implants as treatment of TFA. © 2016 Wiley Periodicals, Inc. J Biomed Mater Res Part A: 105A: 578-589, 2017.

Keywords: gene expression; infection; osseointegration; percutaneous; transfemoral amputees.

© 2016 The Authors Journal of Biomedical Materials Research Part A Published by Wiley Periodicals, Inc.

Figures

Figure 1
Figure 1
An overview of the implant components, the sampling procedures and the clinical assessment of the skin. (A, B) Schematic drawing showing the implant components and surrounding tissue. Abutments with a diameter of 11 mm and a length of 72–77 mm were machined from cp‐Ti grade IV (n = 29) and titanium alloy (Ti6Al4V, grade V) (n = 1), cleaned by ultrasonication followed by sterilisation. (C‐E) Bacterial swabs taken from skin‐penetration site (C), abutment (D) and bone canal (E). (F, G) Retrieval of abutment for macroscopic inspection (F) and placement in a fixed volume of RNAlater (G) for subsequent RNA and protein extraction. (H‐K) Representative skin‐penetration sites for the scoring system: H) Score 0: clean, dry, tight; I) Score 2: purple, serous secretion; J) Score 3: granulation ring, redness; K) Score 4: granulation ring, redness, serous secretion.
Figure 2
Figure 2
Radiological changes (A‐F). (A) The early (after 3 years) postoperative X‐ray from patient 1 (P1). (B) The corresponding X‐ray at the 10‐year post‐operative follow‐up of P1. Proximal trabecular buttressing (an increase of the bone density at the proximal end of the fixture) (thick, black arrow) and cancellisation (an increase in the porosity of the cortex surrounding the fixture) (thin, black arrow) have developed. (C) The early postoperative X‐ray (after the first surgery, S1) from patient 2 (P2). (D) At two‐years, a cortical thinning (a decrease in the width of the cortex around the fixture) (white arrow‐head) is evident. (E) An early postoperative X‐ray from patient 3 (P3) after the second surgery, S2. (F). The X‐ray from patient 3 after seven years, demonstrates endosteal bone resorption (thin, white arrow) and distal bone resorption (thick, white arrow). Endosteal bone resorption is the resorption of endosteal bone around the threads of the fixture, while distal bone resorption is the resorption of the bone at the distal end of the fixture.
Figure 3
Figure 3
Western blot analysis of protein A on the abutment. Examples of positive and negative Staphylococcus aureus protein A detection on abutment. P1: One patient of two who did not demonstrate positive detection of protein A. P2‐P4: Four patients (P2‐P4) with positive bands of Staphylococcus aureus protein A (≈50 kDa) detected in 28/30 patients.
Figure 4
Figure 4
Gene expression of (A) osteocalcin (OC) and (B) interleukin‐10 (IL‐10) in the abutment‐adherent cells. The comparison was performed between patients with osseointegrated fixtures (n = 27) and patients with loosened fixtures (n = 3). Bars indicate statistically significant differences (p < 0.05).
Figure 5
Figure 5
Gene expression of tumour necrosis factor‐alpha (TNF‐α) and matrix metalloproteinase‐8 (MMP‐8) in the abutment‐adherent cells. The comparative analyses were performed as following: (A) TNF‐α expression in patients in whom S. aureus was not detected (n = 16) versus patients in whom S. aureus was detected (n = 14); (B) TNF‐α expression in patients in whom S. aureus was not detected (n = 16) versus patients in whom S. aureus was detected alone (n = 6) or detected with other bacteria (n = 8); (C) MMP‐8 expression in patients in whom S. aureus was not detected (n = 16) versus patients in whom S. aureus was detected alone (n = 6) or detected with other bacteria (n = 8). The bars indicate statistically significant differences (p < 0.05).

References

    1. Branemark R, Berlin O, Hagberg K, Bergh P, Gunterberg B, Rydevik B. A novel osseointegrated percutaneous prosthetic system for the treatment of patients with transfemoral amputation: A prospective study of 51 patients. Bone Joint J 2014;96‐b:106–113.
    1. Juhnke DL, Beck JP, Jeyapalina S, Aschoff HH. Fifteen years of experience with Integral‐Leg‐Prosthesis: Cohort study of artificial limb attachment system. J Rehabil Res Dev 2015;52:407–420.
    1. Khemka A, FarajAllah CI, Lord SJ, Bosley B, Al Muderis M. Osseointegrated total hip replacement connected to a lower limb prosthesis: A proof‐of‐concept study with three cases. J Orthop Surg Res 2016;11:13.
    1. Schalk SA, Jonkergouw N, van der Meer F, Swaan WM, Aschoff HH, van der Wurff P. The evaluation of daily life activities after application of an osseointegrated prosthesis fixation in a bilateral transfemoral amputee: A case study. Medicine (Baltimore) 2015;94:e1416.
    1. Jeyapalina S, Beck JP, Bachus KN, Bloebaum RD. Cortical bone response to the presence of load‐bearing percutaneous osseointegrated prostheses. Anat Rec (Hoboken) 2012;295:1437–1445.
    1. Branemark R, Branemark PI, Rydevik B, Myers RR. Osseointegration in skeletal reconstruction and rehabilitation: A review. J Rehabil Res Dev 2001;38:175–181.
    1. Esposito M, Hirsch JM, Lekholm U, Thomsen P. Biological factors contributing to failures of osseointegrated oral implants. (I). Success criteria and epidemiology. Eur J Oral Sci 1998;106:527–551.
    1. Tjellstrom A, Lindstrom J, Hallen O, Albrektsson T, Branemark PI. Osseointegrated titanium implants in the temporal bone. A clinical study on bone‐anchored hearing aids. Am J Otol 1981;2:304–310.
    1. Tsikandylakis G, Berlin O, Branemark R. Implant survival, adverse events, and bone remodeling of osseointegrated percutaneous implants for transhumeral amputees. Clin Orthop Relat Res 2014;472:2947–2956.
    1. Hagberg K, Haggstrom E, Uden M, Branemark R. Socket versus bone‐anchored trans‐femoral prostheses: Hip range of motion and sitting comfort. Prosthet Orthot Int 2005;29:153–163.
    1. Nebergall A, Bragdon C, Antonellis A, Karrholm J, Branemark R, Malchau H. Stable fixation of an osseointegated implant system for above‐the‐knee amputees: Titel RSA and radiographic evaluation of migration and bone remodeling in 55 cases. Acta Orthop 2012;83:121–128.
    1. McConoughey SJ, Howlin R, Granger JF, Manring MM, Calhoun JH, Shirtliff M, Kathju S, Stoodley P. Biofilms in periprosthetic orthopedic infections. Future Microbiol 2014;9:987–1007.
    1. Tillander J, Hagberg K, Hagberg L, Branemark R. Osseointegrated titanium implants for limb prostheses attachments: Infectious complications. Clin Orthop Relat Res 2010;468:2781–2788.
    1. Malik MH, Jury F, Bayat A, Ollier WE, Kay PR. Genetic susceptibility to total hip arthroplasty failure: A preliminary study on the influence of matrix metalloproteinase 1, interleukin 6 polymorphisms and vitamin D receptor. Ann Rheum Dis 2007;66:1116–1120.
    1. Pigossi SC, Alvim‐Pereira F, Montes CC, Finoti LS, Secolin R, Trevilatto PC, Scarel‐Caminaga RM. Genetic association study between Interleukin 10 gene and dental implant loss. Arch Oral Biol 2012;57:1256–1263.
    1. Chen Q, Jin M, Yang F, Zhu J, Xiao Q, Zhang L. Matrix metalloproteinases: inflammatory regulators of cell behaviors in vascular formation and remodeling. Mediators Inflamm 2013;2013:928315.
    1. Jarmar T, Palmquist A, Branemark R, Hermansson L, Engqvist H, Thomsen P. Technique for preparation and characterization in cross‐section of oral titanium implant surfaces using focused ion beam and transmission electron microscopy. J Biomed Mater Res A 2008;87:1003–1009.
    1. Holgers KM, Tjellstrom A, Bjursten LM, Erlandsson BE. Soft tissue reactions around percutaneous implants: a clinical study of soft tissue conditions around skin‐penetrating titanium implants for bone‐anchored hearing aids. Am J Otol 1988;9:56–59.
    1. Pfaffl MW. A new mathematical model for relative quantification in real‐time RT‐PCR. Nucleic Acids Res 2001;29:e45.
    1. Bustin SA, Benes V, Garson JA, Hellemans J, Huggett J, Kubista M, Mueller R, Nolan T, Pfaffl MW, Shipley GL, J Vandesompele, CT Wittwer. The MIQE guidelines: Minimum information for publication of quantitative real‐time PCR experiments. Clin Chem 2009;55:611–622.
    1. Holgers KM, Källtorp M, Thomsen P. Titanium in soft tissues In: Brunette DM, Textor M, Thomsen P, editors. Titanium in Medicine. Berlin: Springer Verlag; 2001. p 513–560.
    1. Hagberg K, Branemark R. Consequences of non‐vascular trans‐femoral amputation: A survey of quality of life, prosthetic use and problems. Prosthet Orthot Int 2001;25:186–194.
    1. Hagberg K, Hansson E, Branemark R. Outcome of percutaneous osseointegrated prostheses for patients with unilateral transfemoral amputation at two‐year follow‐up. Arch Phys Med Rehabil 2014;95:2120–2127.
    1. Buikema KE, Meyerle JH. Amputation stump: Privileged harbor for infections, tumors, and immune disorders. Clin Dermatol 2014;32:670–677.
    1. Allende MF, Barnes GH, Levy SW, O'Reilly WJ. The bacterial flora of the skin of amputation stumps. J Invest Dermatol 1961;36:165–166.
    1. DeDent AC, McAdow M, Schneewind O. Distribution of protein A on the surface of Staphylococcus aureus. J Bacteriol 2007;189:4473–4484.
    1. Eron LJ, Lipsky BA, Low DE, Nathwani D, Tice AD, Volturo GA. Managing skin and soft tissue infections: Expert panel recommendations on key decision points. J Antimicrob Chemother 2003;52:i3–17.
    1. Ellis Simonsen SM, van Orman ER, Hatch BE, Jones SS, Gren LH, Hegmann KT, Lyon JL. Cellulitis incidence in a defined population. Epidemiol Infect 2006;134:293–299.
    1. Zaborowska M, Tillander J, Brånemark R, Hagberg L, Thomsen P, Trobos M. Biofilm formation and antimicrobial susceptibility of staphylococci and enterococci from osteomyelitis associated with percutaneous orthopaedic implants. J Biomed Mater Res Part B 2016;00B:000–000.
    1. Busscher HJ, van der Mei HC, Subbiahdoss G, Jutte PC, van den Dungen JJ, Zaat SA, Schultz MJ, Grainger DW. Biomaterial‐associated infection: Locating the finish line in the race for the surface. Sci Transl Med 2012;4:153rv10.
    1. Couper KN, Blount DG, Riley EM. IL‐10: The master regulator of immunity to infection. J Immunol 2008;180:5771–5777.
    1. Garlet GP, Martins W Jr, Fonseca BA, Ferreira BR, Silva JS. Matrix metalloproteinases, their physiological inhibitors and osteoclast factors are differentially regulated by the cytokine profile in human periodontal disease. J Clin Periodontol 2004;31:671–679.
    1. Heim CE, Vidlak D, Kielian T. Interleukin‐10 production by myeloid‐derived suppressor cells contributes to bacterial persistence during Staphylococcus aureus orthopedic biofilm infection. J Leukoc Biol 2015;98:1003–1013.

Source: PubMed

3
購読する